f Post-Approval Studies (PAS) Database
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Post-Approval Studies (PAS) Database

  • Print
  • Share
  • E-mail

The FDA has the authority to require sponsors to perform a post-approval study (or studies) at the time of approval of a premarket approval (PMA), humanitarian device exemption (HDE), or product development protocol (PDP) application. Post-approval studies can provide patients, health care professionals, the device industry, the FDA and other stakeholders information on the continued safety and effectiveness (or continued probable benefit, in the case of an HDE) of approved medical devices. This database allows you to search Post-Approval Study information by applicant or device information.

Learn more...


Enhanced Surveillance

Suggest Enhancement / Report Issue | export reports to excelExport to Excel
Study Status Progress Adequate
Application Number /
Requirement Number
P100003 / PAS002
Date Original Protocol Accepted 09/28/2012
Date Current Protocol Accepted 05/08/2014
Study Name Enhanced Surveillance
General Study Protocol Parameters
Study Design Enhanced Surveillance
Data Source New Data Collection
Comparison Group No Control
Analysis Type Descriptive
Detailed Study Protocol Parameters
Study Objectives Objectives-To assess safety profile of the secure-C disc under general condition of use. Design- ESS
Study Population All patients who have received secure-C
Sample Size N/A
Key Study Endpoints Anticipated and un-anticipated adverse events including, but
not limited to major vessel injury, neurological damage, or nerve injury, device migration, removal, revision, and heterotopic codification.
Follow-up Visits and Length of Follow-up 10 years
Assessments: Annual for surgeon surveys, ongoing for the complains, explants and MDRs

Enhanced Surveillance Reporting Schedule

Reporting Schedule
Date Due
FDA Receipt
Applicant's Reporting Status
6 month report 03/29/2013 03/28/2013 On Time
1 year report 09/28/2013 09/27/2013 On Time
18 month report 03/29/2014 03/28/2014 On Time
2 year report 09/28/2014 09/26/2014 On Time
3 year report 09/28/2015 09/30/2015 Overdue/Received
4 year report 09/27/2016 09/28/2016 Overdue/Received
5 year report 09/27/2017 09/28/2017 Overdue/Received
6 year report 09/27/2018 09/27/2018 On Time
7 year report 09/27/2019 09/26/2019 On Time
8 year report 09/27/2020 09/25/2020 On Time
9 year report 09/28/2021 09/28/2021 On Time
10 year report 09/28/2022 09/27/2022 On Time
11 year report 09/28/2023    

Contact Us

Mandated Studies Program
Food and Drug Administration
10903 New Hampshire Ave.
Silver Spring, MD 20993-0002
Email: MandatedStudiesPrograms@fda.hhs.gov

Additional Resources